Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 9.64 Delayed Data As of 6:30pm ET |  -0.16 / -1.63%Today’s Change | 6.07 Today|||52-Week Range 20.21 | -37.48% Year-to-Date |
Latest TEVA News | Press Releases
| Save Yourself the Migraine and Buy This 1 Pharma Stock Now Dec 06 / MotleyFool.com - Paid Partner Content | Why Sorrento Therapeutics Was Right to Reject Takeover Bids With A 245% Premium Dec 05 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 9.80 |
| Today’s open | 9.91 |
| Day’s range | 9.61 - 9.97 |
| Volume | 13,520,971 |
| Average volume (3 months) | 21,305,015 |
| Market cap | $10.8B |
Data as of 6:30pm ET, 12/13/2019
Growth & Valuation
| Earnings growth (last year) | +85.71% |
| Earnings growth (this year) | -18.37% |
| Earnings growth (next 5 years) | +1.70% |
| Revenue growth (last year) | -16.69% |
| P/E ratio | NM |
| Price/Sales | 0.84 |
| Price/Book | 0.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BGNEBeigene Ltd | -3.14 | -1.75% |
| BBIOBridgeBio Pharma Inc | -0.95 | -2.54% |
| AKRXAkorn Inc | -0.15 | -4.20% |
Data as of 4:15pm ET, 12/13/2019
Financials
| Next reporting date | February 7, 2020 |
| EPS forecast (this quarter) | $0.61 |
| Annual revenue (last year) | $18.8B |
| Annual profit (last year) | -$2.1B |
| Net profit margin | -11.40% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Petach Tikva, Hamerkaz |
Forecasts
